Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol in Clopidogrel Non-Responders After Drug-Eluting Stent Implantation

NCT00620646 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT00620646
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00620646 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Comparison of Effects Between Increased Dose of Clopidogrel and Addition of Cilostazol in Clopidogrel Non-Responders After Drug-Eluting Stent Implantation
Lead sponsor
Samsung Medical Center
Phase
Not applicable
Overall status
Completed
Start date
February 29, 2008
Completion date
February 28, 2009
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clopidogrel non-responsiveness